This product is isolated and purified from the herbs of Daphniphyllum paxianum
Methyl (1S,2S,3R,5R,6S,8R,10S)-2,6-dimethyl-21-oxo-14-oxa-8-azahexacyclo[18.104.22.168.0.0.0]henicosa-13(20),17-diene-18-carboxylate 8-oxide/2H-10,11c-Methanopyrano[4',3',2':1,8]azuleno[4,5-a]indolizine-13-carboxylic acid, 1,4,5,5a,6,8,9,10,11,11a,11b,12-dodecahydro-9,11b-dimethyl-14-oxo-, methyl ester, 7-oxide, (5aS,7R,9S,10R,11aR,11bS,11cS)-
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
HS Code Reference
Personal Projective Equipment
For Reference Standard and R&D, Not for Human Use Directly.
provides coniferyl ferulate(CAS#:1092555-03-7) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate
Patients with glioblastoma multiforme (GBM) are immunosuppressed and have a broad range of immunological defects in both innate and adaptive immune responses. GBMs are frequently infected with human cytomegalovirus (HCMV), a virus capable of causing immunosuppression. In 42 HCMV-positive GBM patients in a clinical trial (VIGAS), we investigated T-cell phenotypes in the blood and assessed their relation to survival. Blood was collected before and 3, 12, and 24 weeks after surgery, and the frequency of T-cell subsets was compared with that in 26 age-matched healthy controls. GBM patients had lower levels of CD3 cells than the controls, but had significantly higher levels of CD4+CD28− T cells before and 3 and 12 weeks after surgery and increased levels of CD4+CD57+ and CD4+CD57+CD28+ T cells at all-time points. These T-cell subsets were associated with both immunosenescence and HCMV infection. GBM patients also had higher levels of γδ T cells at all-times after surgery and lower levels of CD4+CD25+ cells before and 3 weeks after surgery than healthy controls. Overall survival was significantly shorter in patients with higher levels of CD4+CD28− T cells (p = 0.025), CD4+CD57+ T (p = 0.025) cells, and CD4+CD28−CD57+CD28− T cells (p < 0.0004) at 3 weeks after surgery. Our findings indicate that signs of immunosenescence in the CD4+ compartment are associated with poor prognosis in patients with HCMV-positive GBMs and may reflect the HCMV activity in their tumors.
cytomegalovirus, glioblastoma, immunosenescence, survival, T cells
Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery
Olesja Fornara,1 Jenny Odeberg,1 Nina Wolmer Solberg,1 Charlotte Tammik,1 Petra Skarman,1 Inti Peredo,1,2 Giuseppe Stragliotto,1,3 Afsar Rahbar,1,$* and Cecilia Soderberg-Naucler1,$